Quite possibly, this manuscript is projected to have the highest impact on patient care and industry for the immediate future.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
November 14, 2022
July 11, 2022
There could be some translational value for cardiovascular surgical practice from this prospective cardiovascular health study. The mechanistic link warrants further investigation and interpretation.
Treatment of Carotid Stenosis in Asymptomatic, Nonoctogenarian, Standard Risk Patients with Stenting Versus Endarterectomy Trials
July 1, 2022
This is an interesting, well-written account of pooled results of two medium-size RCTs . It would be interesting to see a third arm of optimum medical therapy in follow-up studies ...
March 30, 2022
Interesting case-control study on variations of aortovascular compliance
June 11, 2021
A useful detailed review (or state-of-the-art article) on revascularisation in extracardiac vascular stenoocclusive atheromatosis.
December 20, 2020
A scholarly metanalytic review on training by surgical simulators. The authors submit that low-fidelity is acceptable, balancing affordable basic inanimate models against the higher cost (and ethics) of zootomy and cadaceric dissection.
December 10, 2020
An ad hoc interim analysis pursuant to previous publications raising concerns on Paclitaxel DCS in chronic critical and not-critical lower limb ischaemia. The short manuscript requires careful reading to form an individual opinion beyond the relatively simple arithmetics: slightly more deaths in the intervention group.
September 7, 2020
Patients with aneurysms 7 cm or greater demonstrated a higher probability of survival when treated immediately, compared to delayed repair, for patients under 80 years of age. An interesting attempt to construct a decision tool for aortic aneurysms.
Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery Disease - VOYAGER PAD
April 1, 2020
Short but promising follow-up: the intervention appears again to trade off short-term peripheral vascular complications for hitherto semi-qualified MAJOR bleed in patients undergoing revascularization for peripheral vascular disease, for an assumed considerable financial cost.
miR-128-3p Is a Novel Regulator of Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Diseases
March 30, 2020
Interesting to follow up the translational potential of this rodent-model of carotid i